Drug Approval | August 24, 2023
Briefs: J B Chemicals & Pharmaceuticals updates and Torrent Pharmaceuticals
The drug will be manufactured at JB Pharma's formulation manufacturing facility in Panoli, Gujarat
The drug will be manufactured at JB Pharma's formulation manufacturing facility in Panoli, Gujarat
Eris Lifesciences enters into term loan agreement with Citi Bank
The deal represents a total transaction value of up to $36 million with an initial upfront consideration of $14 million
Oteseconazole Capsules were found to be safe and more effective than fluconazole
Aurobindo's product is already filed with the Drugs Controller General of India (DCGI) and is expected to be approved soon
Glenmark's current portfolio consists of 184 products authorized for distribution in the U.S. marketplace
Lupin actively contributes to alleviating the burden of COPD for patients across the nation
Deep Transcranial Magnetic Stimulation (dTMS) is a non-invasive brain stimulation technique approved by regulatory authorities, including the USFDA
US FDA approval is in line with de-risking strategy for additional API site to service our global customer base
The inspection closed with zero observations and a classification of No Action Indicated
Subscribe To Our Newsletter & Stay Updated
